Clinical Trial Update: Protecting Preterm Infants From Respiratory Tract Infections and Wheeze by Using Bacterial Lysates. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating bacterial lysates to protect preterm infants from lower respiratory tract infections and wheeze; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Respiratory Tract Infection
• Wheezing

Drugs mentioned

• Bacterial lysates

Snippet

Sponsor: Franciscus Gasthuis | Conditions: Wheezing, LRTI | Phase 3 | Status: RECRUITING